Objective To assess the diagnostic and clinical utility of the 2-item Generalized Anxiety
Disorder Scale (GAD-2) for screening anxiety symptoms in individuals with multiple sclerosis
(MS). Design Cross-sectional. Setting University-affiliated MS neurology and rehabilitation
center. Participants The sample comprised adults (N= 99)(ages 19-72; mean±SD=
46.2±13.0; 75% women) with a physician-confirmed MS diagnosis who were receiving care
in a university-affiliated MS center. Disease durations ranged from 1 to 37 years (mean±SD …